Return to work after COVID-19 infection - A Danish nationwide registry study.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 08 10 2021
revised: 05 11 2021
accepted: 15 12 2021
pubmed: 18 1 2022
medline: 2 2 2022
entrez: 17 1 2022
Statut: ppublish

Résumé

This study aimed to explore return to work after COVID-19 and how disease severity affects this. This is a Nationwide Danish registry-based cohort study using a retrospective follow-up design. Patients with a first-time positive SARS-CoV-2 polymerase chain reaction test between 1 January 2020 and 30 May 2020, including 18-64 years old, 30-day survivors, and available to the workforce at the time of the first positive test were included. Admission types (i.e. no admission, admission to non-intensive care unit [ICU] department and admission to ICU) and return to work was investigated using Cox regression standardised to the age, sex, comorbidity and education-level distribution of all included subjects with estimates at 3 months from positive test displayed. Among the 7466 patients included in the study, 81.9% (6119/7466) and 98.4% (7344/7466) returned to work within 4 weeks and 6 months, respectively, with 1.5% (109/7466) not returning. Of the patients admitted, 72.1% (627/870) and 92.6% (805/870) returned 1 month and 6 months after admission to the hospital, with 6.6% (58/870) not returning within 6 months. Of patients admitted to the ICU, 36% (9/25) did not return within 6 months. Patients with an admission had a lower chance of return to work 3 months from positive test (relative risk [RR] 0.95, 95% confidence interval [CI] 0.94-0.96), with the lowest chance in patients admitted to an ICU department (RR 0.54, 95% CI 0.35-0.72). Female sex, older age, and comorbidity were associated with a lower chance of returning to work. Hospitalised patients with COVID-19 infection have a lower chance of returning to work with potential implications for postinfection follow-up and rehabilitation.

Identifiants

pubmed: 35038630
pii: S0033-3506(21)00473-X
doi: 10.1016/j.puhe.2021.12.012
pmc: PMC8786635
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-122

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Lancet Respir Med. 2021 Mar;9(3):251-259
pubmed: 33341155
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
BMC Public Health. 2021 May 31;21(1):1023
pubmed: 34059034
J Clin Med. 2020 Dec 09;9(12):
pubmed: 33317214
Clin Infect Dis. 2021 Dec 6;73(11):e4025-e4030
pubmed: 32634827
Eur Respir J. 2020 Oct 15;56(4):
pubmed: 32764112
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Int J Epidemiol. 2021 Nov 10;50(5):1745-1747
pubmed: 34458903
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Scand J Public Health. 2011 Jul;39(7 Suppl):26-9
pubmed: 21775346
Occup Med (Lond). 2021 Oct 1;71(6-7):243-244
pubmed: 33205200
Health Econ. 2009 Feb;18(2):161-79
pubmed: 18536002
Scand J Public Health. 2007;35(5):497-502
pubmed: 17852980
Front Public Health. 2020 Oct 19;8:580546
pubmed: 33194983
BMC Public Health. 2010 Nov 24;10:724
pubmed: 21106057
Crit Care Med. 2021 Nov 1;49(11):e1157-e1162
pubmed: 34048368
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Int J Infect Dis. 2021 Feb;103:316-322
pubmed: 33279652
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
Clin Epidemiol. 2013;5:9-12
pubmed: 23359787
Scand J Public Health. 2011 Jul;39(7 Suppl):91-4
pubmed: 21775362

Auteurs

P A Jacobsen (PA)

Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark; The Clinical Institute, Aalborg University, Aalborg, Denmark. Electronic address: peter.jacobsen@rn.dk.

M P Andersen (MP)

Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark.

G Gislason (G)

Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Copenhagen, Denmark; The Danish Heart Foundation, Copenhagen, Denmark.

M Phelps (M)

The Danish Heart Foundation, Copenhagen, Denmark.

J H Butt (JH)

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.

L Køber (L)

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.

M Schou (M)

Department of Cardiology, Copenhagen University Hospital Herlev-Gentofte, Copenhagen, Denmark.

E Fosbøl (E)

Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark.

H C Christensen (HC)

Copenhagen Emergency Medical Services, Copenhagen, Denmark.

C Torp-Pedersen (C)

Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark; Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

T Gerds (T)

Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark.

U M Weinreich (UM)

Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark; The Clinical Institute, Aalborg University, Aalborg, Denmark.

K Kragholm (K)

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH